Tumour Markers in Peritoneal Washing Fluid - Contribution to Cytology |
Yildirim, Mustafa
(Department of Medical Oncology, Ministry of Health Batman Regional Govermant Hospital)
Suren, Dinc (Department of Pathology, Antalya Education and Research Hospital) Yildiz, Mustafa (Department of Medical Oncology, Antalya Education and Research Hospital) Alikanoglu, Arsenal Sezgin (Department of Pathology, Antalya Education and Research Hospital) Kaya, Vildan (Department of Radiation Oncology, Suleyman Demirel University) Doluoglu, Suleyman Gunhan (Department of Obstetrics and Gynecology, Antalya Education and Research Hospital) Aydin, Ozgur (Department of Biochemistry, Antalya Education and Research Hospital) Yilmaz, Necat (Department of Biochemistry, Antalya Education and Research Hospital) Sezer, Cem (Department of Pathology, Antalya Education and Research Hospital) Karaca, Mehmet (Department of Obstetrics and Gynecology, Antalya Education and Research Hospital) |
1 | Ismail MA, Rotmensch J, Mercer LJ, et al (1994). CA-125 in peritoneal fluid from patients with nonmalignant gynecologic disorders. Reprod Med, 39, 510-2. |
2 | Kashimura M, Sugihara K, Toki N, et al (1997). The signifi cance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol, 67, 285-90. DOI ScienceOn |
3 | Mlyneek M, Uhareek P (2005). Peritoneal cytology in endometrial cancer. Neoplasma, 52, 103-8. |
4 | Sankaranarayanan R, Ferlay J (2006). Worldwide burd of gynaecological cancer; the size of the problem. Bailliere's Best Pract Res, 20, 207-25, DOI ScienceOn |
5 | Sari R, Yildirim B, Sevinc A, Bahceci F, Hilmioglu F (2001). The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology. Hepatogastroenterology, 48, 1616-21. |
6 | Selvaggi SM (2003). Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis. Diagn Cytopathol, 28, 335-41. DOI ScienceOn |
7 | Sharifi S, Ducatman BS, Wang HH, Fraser JL (1999). Peritoneal washing cytology is unnecessary in gynecologic surgery for benign diseases. Cancer Cytopathol, 87, 259-62. DOI |
8 | Shield P (2004). Peritoneal washing cytology. Cytopathology, 15, 131-41. DOI ScienceOn |
9 | Sneige N, Thomison JB, Malpica A, et al (2012). Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome. Cancer Cytopathol, 120, 238-44. DOI |
10 | Takeshima N, Katase K, Hirai Y, et al (1997). Prognostic value of peritoneal cytology in patients with carcinoma of the uterine cervix. Gynecol Oncol, 64, 136-40 DOI ScienceOn |
11 | Topalak O, Saygili U, Soyturk M, et al (2002). Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study. Gynecol Oncol, 85, 108-13. DOI ScienceOn |
12 | Tuzun Y, Celik Y, Bayan K, et al (2009). Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt? J Int Med Res, 37, 79-86. DOI |
13 | Yoon SM, Shin KH, Kim JY, et al (2007). The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy. Int J Gynecol Cancer, 17, 872-8. DOI ScienceOn |
14 | Yurkovetsky Z, Skates S, Lomakin A, et al (2010). Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol, 28, 2159-66. DOI ScienceOn |
15 | Zuna RE, Behrens A (1996). Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. J Natl Cancer Inst, 88, 980-7. DOI ScienceOn |
16 | Anastasiadis P, Koutlaki N, Liberis V, et al (2011). The contribution of rapid intraoperative cytology in the evaluation of endometrial cancer spread. Ann Acad Med Singapore, 40, 80-3. |
17 | Barbati A, Anceschi MM, Di Renzo GC, et al (1992). CA 125 in peritoneal fluid: reliable values at high dilutions. Obstet Gynecol, 79, 1011-5. |
18 | Gadducci A, Ferdeghini M, Prontera C, et al (1992). The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol Oncol, 44, 147-54. DOI ScienceOn |
19 | Harlozinska A, Bar JK, Gawlikowski W, et al (1991). CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms. Ann Chir Gynaecol, 80, 368-75. |
20 | Gadducci A, Tana R, Cosio S, et al (2008). The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature. Crit Rev Oncol Hematol, 66, 10-20. DOI ScienceOn |